PREDICTive value of aggressive risk factor modification on the development of atrial fibrillation in Embolic Stroke of Undetermined Source. Staging the Atrial Fibrillation Substrate: The PREDICT-ESUS study
- Conditions
- Atrial fibrillationStrokeCardiovascular - Other cardiovascular diseasesStroke - Ischaemic
- Registration Number
- ACTRN12620000771954
- Lead Sponsor
- niversity of Adelaide
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 400
oPrimary diagnosis of ESUS
oNo history of documented atrial fibrillation or flutter during 24 hours of ward telemetry or ambulatory Holter monitoring
oNo known history of AF or flutter
oDocumented atrial fibrillation or flutter prior to randomisation
oSerious Underlying Medical Disorder
oAge < 18
oInability to Provide Informed Consent
oBeing fully anticoagulated prior to randomisation
oModerate-Severe Valvular Heart disease
oProsthetic Heart Valve
oEndocrinopathy including subclinical thyroid disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method